Epidermal growth factor receptor (EGFR) inhibitors - TKI (Latest Month)
$4,999.00
SocialSWOT for Epidermal growth factor receptor (EGFR) inhibitors (TKI) is a report published every month by Semantelli to uncover Strengths, Weaknesses, Opportunities and Threats in the online and social media space for the following brands.
- Table of Contents
- Summary SWOT for the month
- Analyzed and compiled by our team, the SWOT report will contain Strengths, Weakness, Opportunities and Threats based on online and social data for each brand.
- Search Statistics for the month
- Top key words used by people to search for the brands and disease states
- Search volume for each brand
- Regional search trends
- Emerging key words
- Social Media Statistics for the month
- Discussion Forums
- Blogs
- Top topics discussed during the month.
- Monthly Social Media Sentiment for each brand
- Any Wikipedia updates occurred during the month for each brand
- Top 10 online communities where patients have conversations about the brands and diseases states
- Top 5 Social Advocates who influence patients and peers
- New Clinical Trials, Publications and FDA Alerts for each brand
